+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm



Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm



Chest 143(4): 896-900



Compounding pharmacies serve a critical role in modern health care to meet special patient care needs. Although the US Food and Drug Administration (FDA) has clearly delineated jurisdiction over drug companies and products manufactured under Good Manufacturing Practice (GMP) regulations to ensure quality, potency, and purity, compounding pharmacies are regulated by the State Boards and are not registered by the FDA. In recent years, some compounding pharmacies acted like a manufacturer, preparing large amounts of injectable drugs with interstate activities. Multiple outbreaks have been linked to compounding pharmacies, including a recent outbreak of fungal meningitis related to contaminated methylprednisolone, exposing > 14,000 patients in multiple states. This tragedy underscores the urgency of addressing safety related to compounding pharmacies. There is a call for action at the federal and state levels to set minimum production standards, impose new labeling conditions on compounded drugs, and require large-scale compounders be regulated by the FDA. "Industrial" compounding must come under FDA oversight, require those pharmacies to meet GMP standards, and ensure quality and safe products for patient use. Moreover, compliance with the Institute for Safe Medication Practices 2011 recommendations that any type of sterile compounding must be in compliance with the United States Pharmacopoeia chapter 797 guidelines will reduce the risk of patient harm from microbial contamination. Finally, other critical factors that require close attention include addressing injectable products compounded in hospitals and other outpatient health-care centers. The FDA and State Boards of Pharmacy must be adequately funded to exercise the oversight effectively.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269373

Download citation: RISBibTeXText

PMID: 23412546

DOI: 10.1378/chest.13-0212


Related references

New Paradigm of Live Surgical Education: Synchronized Deferred Live Surgery. Journal of the American College of Surgeons 227(4): 467-473, 2018

Relevant activity and performance indicator for pharmacy compounding Benchmarking for two oncology drugs compounding pharmacy laboratories. Le Pharmacien Hospitalier et Clinicien 48(2), 2013

Measuring anthropogenic influence on molluscan populations of Masonboro Inlet, North Carolina, using live-dead and live-live assemblages. Geological Society of America 42.1, 2010

The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney International 56(1): 1-17, 1999

Pharmacy Compounding Accreditation Board: past, present, and future. International Journal of Pharmaceutical Compounding 18(6): 526-527, 2015

Meat. A summary of figures of production, trade and consumption relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals. Meat. A summary of figures of production, trade and consumption relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, London : H.M.S.O., x + 91. Price: 5s,, 1948

Meat. A summary of figures of production, trade and consumption relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Meat. A summary of figures of production, trade and consumption relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat, London : H. M. S. O., xii + 99. Price: 5s,, 1952

Meat. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Compiled in the Intelligence Branch of the Commonwealth Economic Committee, London: H. M. S. O., iv + 112. Price: 5s,, 1958

Meat, 1963, No. 15. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Meat, No. 15. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat, London: H. M. S. O., viii + 148. Price: 7s. 6d,, 1964

Meat, 1960, No. 12. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Meat, No. 12. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat, London: H. M. S. O., vii + 132. Price: 7s. 6d,, 1961

The old care paradigm is dead, long live the new sustainable care paradigm: how can GP commissioning consortia meet the demand challenges of 21st century healthcare?. London Journal of Primary Care 4(1): 64-68, 2011

Meat. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Compiled in the Intelligence Branch of the Commonwealth Economic Committee. Meat. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Compiled in the Intelligence Branch of the Commonwealth Economic Committee, London: H. M. S. O., iv + 104. Price: 5s,, 1957

Meat. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Compiled in the Intelligence Branch of the Commonwealth Economic Committee. Meat. A review of production, trade, consumption and prices relating to beef, live cattle, mutton and lamb, live sheep, bacon and hams, pork, live pigs, canned meat, offals, poultry-meat. Compiled in the Intelligence Branch of the Commonwealth Economic Committee, London: H. M. S. O., iv + 108. Price: 5s,, 1954

Judge allows bulk ingredients for compounding: ruling favors pharmacy, but FDA can still distinguish manufacturing, compounding. Journal of the American Veterinary Medical Association 239(10): 1266-1268, 2012

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future. International Journal of Pharmaceutical Compounding 21(4): 293-298, 2017